Skip to Main Content

Paper Details

Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.
Sci Transl Med
11
2023
Author NameAffiliation
Nazanin TatariUniversity Hospital and University of Basel
Michael WellerClinical Neuroscience Center, University Hospital and University of Zurich
Tobias WeissClinical Neuroscience Center, University Hospital and University of Zurich
  • 1 - 3

Datasets

Release 1.2